Radioimmunotherapy Improves Survival of Rats with Microscopic Liver Metastases of Colorectal Origin

BACKGROUND: Half of the patients with colorectal cancer develop liver metastases during the course of their disease. The aim of the present study was to assess the efficacy of radioimmunotherapy (RIT) with a radiolabeled monoclonal antibody (mAb) to treat experimental colorectal liver metastases. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: de Jong, Gabie M., Hendriks, Thijs, Eek, Annemarie, Oyen, Wim J. G., Heskamp, Sandra, Bleichrodt, Robert P., Boerman, Otto C.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Translational Research and Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695874/
https://www.ncbi.nlm.nih.gov/pubmed/19430843
http://dx.doi.org/10.1245/s10434-009-0477-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695874/
https://www.ncbi.nlm.nih.gov/pubmed/19430843
http://dx.doi.org/10.1245/s10434-009-0477-6

Ejemplares similares